Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

How Does the Pharma Industry Fit into China's Grand Puzzle of Healthcare Reform? Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis recent healthcare reform moves in particular restructure of ... (9/30/2018) Targeting the Affluent: Differential Access to Targeted Therapies in China (10/16/2018) How to Fulfil Chin'’s Potential for Carrying Out Clinical Trials (10/15/2018) Exploring Ways to Establish Presence in China as Part of APAC Region Push: Lupin Pharma (10/15/2018) China: AstraZeneca’s New Engine for Growth and Innovation (10/9/2018) Biosimilars and Healthcare Policy: What China Can Learn from the EU and US (10/8/2018) Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs (10/8/2018) SCMP: Betting Big on Biotech (10/8/2018) How Does the Pharma Industry Fit into China's Grand Puzzle of Healthcare Reform? (9/30/2018) China’s Health Authorities Issue New Rules on Telemedicine (9/27/2018) The Development of Antibody-drug Conjugates in China (9/27/2018) Reuters: As China Builds Biotech Sector, Cash Floods U.S. Startups (9/26/2018) Chinese Pharma Market Primed for Growth after Sweeping Reforms (9/25/2018) Impending Tariffs on China to Impact Manufacturers of Dietary Supplements, OTC Drugs and Cosmetics (9/21/2018) Should You Look At China For Your Next Clinical Trial? (9/20/2018) AstraZeneca Plots China Robot Offensive to Counter Price Cuts (9/19/2018) CDE Publicizes Batch 33 of Drug Applicat...  (10/17/2018) Eisai's NDA for Antiepileptic Perampanel...  (10/17/2018) DiaMedica and Fosun Subsidiary Signs Lic...  (10/16/2018) Alphamab's HER2 Bispecific Antibody KN02...  (10/16/2018) CStone Receives U.S. IND Approval for PD...  (10/16/2018) Changchun Changsheng Biotech Fined CNY 9...  (10/16/2018) Innovent Aims to Raise Up To $422M in Ho...  (10/15/2018) Innovent Granted Chinese IND for Sintili...  (10/15/2018) Zheijiang Huahai Placed under Increased ...  (10/15/2018) NHC Outlines Drug Administrative Policy ...  (10/15/2018) Eisai's NDA for Antiepileptic Drug Peram...  (10/12/2018) Mesoblast and Tasly Complete Strategic C...  (10/12/2018) (free) NEJM and CCA Enter Partnership for CVS R...  (10/11/2018) MEI Pharma and BeiGene Announce Collabor...  (10/11/2018) State Council Issues New Document to Ref...  (10/11/2018) Top 25 Global Pharmaceutical Companies by Market Cap 201... CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Mar... Snapshot of Chinese Public Hospital Vaccine Consumption 2017 China CDMO Market 2018-2021: The R&D Cost of New Drugs Cont... IQVIA: Chinese Hospital Drug Market Up 3.7% in MAT Q1/2018 IQVIA: Chinese Retail Pharmacy Market Surged 4.6% in MAT Q1/201... DiaMedica and Fosun Subsidiary Signs License Agreement for S... Changchun Changsheng Biotech Fined CNY 9.1B in Vaccine Scand... Innovent Aims to Raise Up To $422M in Hong Kong IPO NHC Outlines Drug Administrative Policy Directions and Tasks... Eisai's NDA for Antiepileptic Drug Perampanel Accepted in Ch... CDE Publicizes Batch 33 of Drug Applications To Be Grant... State Council Issues New Document to Reform Licensing Me... CDE Solicits Comments on Technical Requirements for Manu... NMPA Issues Rules for Communications Related to Drug R&a... NMPA Issues Announcement Regarding Direct ADR Reporting ... New U.S. Rules on Foreign Investment to Curb Chinese Goldrus... Chinese Prof at MD Anderson Cancer Center under Scrutiny for... Chinese American Scientist Admits Plot to Steal GSK's Secret... Trump Lashes Out on China and Mexico for Opioid and Fentanyl... Gilead's Key Sovaldi Patent Claims Partially Invalidated in ... Zheijiang Huahai Placed under Increased Supervision EU, U.S. and Canada Investigating Second Impurity in Hua... EU Regulators Issue Notice on a Chinese Anticancer API A... USFDA Recalls Thyroid Drugs Containing Chinese API over ... Indian Drugmakers Hit by Rising Prices of Chinese Interm... Eisai's NDA for Antiepileptic Perampanel Accepted in Chi... Alphamab's HER2 Bispecific Antibody KN026 Gains US IND CStone Receives U.S. IND Approval for PD-L1 Antibody CS1... Innovent Granted Chinese IND for Sintilimab/Bevacizumab ... Innovent to Start US Trials of Anti-CD47 Cancer Drug NEJM and CCA Enter Partnership for CVS Research and Trai... SMIA Issues Official Notice on Approval of 17 Anticancer... China's HIV/AIDS Cases Rise by 14% NHC Reports Higher Health Literacy in China NHC Issues Numerous Clinical Guidelines Recent Official and Executive Moves Recent Executive Moves Recent Official and Executive Movements Recent Executive Moves Eric Bouteiller Joins Advisory Board of WiCON|Pharma China... Upcoming Event: Shanghai eHealth Workshop Upcoming Event: World Congress on Virology 2018 Upcoming Event: GUT Health Congress Asia 2018 Upcoming Event: 5th World Congress on Epigenetics and Ch... Upcoming Event: 7th International Conference on Neurolog... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links